March 2021

Letter from the Editor

March 1, 2021

Thank you… Our special Patient Voice issue is one of my favorite issues of the year. Now in its fourth year, this is our opportunity to shine a light on the people who are truly making a difference to the healthcare system. It’s their unwavering pursuit to change the status quo and improve the delivery […]

Upfront

March 1, 2021

Lilly and Life for a Child Expand Partnership Lilly, Life for a Child, and Beyond Type 1 advance access to diabetes care in resource-limited countries. More than 1.8 million children and young adults under 25 years old have Type 1 diabetes, yet many don’t have access to the life-saving treatments they need, including insulin. In […]

HealthTech

March 1, 2021

Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone Trend Watch: Google, Microsoft, Apple Watch, Azure Becoming Major Players in HealthTech Biogen has initiated a new virtual research study, in collaboration with Apple, to investigate the role Apple Watch and iPhone could play in monitoring cognitive performance […]

Artificial Intelligence

March 1, 2021

90% of Large Pharma Initiated AI/ML Projects In 2020 Trend Watch: AI Use Grows in Drug Research, Development, Analysis, and Diagnosis Trinity Life Sciences is sharing findings from its latest TGaS Landscape report entitled “Perspectives on Use of Artificial Intelligence/Machine Learning (AIML) for Driving Commercial Performance.” The report, based on responses from 23 different biopharma […]

Patient Power: Personal Journeys of Courage

March 1, 2021

The power of patients is palpable, powerful, and pervasive. Patient-centricty has evolved into patient engagement. The distinction, while subtle, is also palpable, powerful, and pervasive. Engagement requires active participation. Rather than being passively placed in the center of vague initiatives, patients are actively engaging in strategic decisions that affect their health and that of others. […]

Unflagging Courage — Dana Deighton

March 1, 2021

As both a caregiver and a patient, I’ve had lots of on-the-job training. It started when I was 32, with young kids, my mom (who was an RN) was diagnosed at age 61 with stage four colon cancer. She only lived for another six weeks and those six weeks were fraught with gut-wrenching pain, smells […]

Bringing Health Equity to All Patients

March 1, 2021

Health equity has long been an issue for communities of color. This past year, the Black Lives Matter movement and recognition of the impact of COVID-19 on many communities has shed new light on the problem of health inequity. Social determinants of health (SDH) remain a huge barrier to health equity. The World Health Organization […]

Advocacy Cheerleader — Barby Ingle

March 1, 2021

I have been battling chronic pain since 1997. First with endometriosis, which resulted in a full hysterectomy and left oophorectomy. Then in 2002, I developed Reflex Sympathetic Dystrophy (RSD), which is also known as Central Pain Syndrome. This is a progressive neuro-autoimmune condition that affects multiple systems in the body and needs to be treated […]

The Patient Knows Best

March 1, 2021

The patient voice is crucial throughout the entire healthcare process, but especially relevant in creating spot-on patient education. Shantana Hazel, Wayne Eskridge, and Lisa Lurie are just three of thousands of patient activists who have used their own patient journey and experiences to create informational and support tools for others. Through their own experience, they […]

Education is Key — Daniel Garza

March 1, 2021

I remember being at Ben Taub Hospital in Houston. Texas. September 2000, I think it was Tuesday the 26th. I had been in the hospital over the weekend, weighed about 110 lbs. with a T-cell count of 108, and the diagnosis was AIDS. I had been in an isolated room, with only my mother, father, […]

Virtual Patient Care: Starting to Shine

March 1, 2021

Virtual patient care has moved from healthcare’s bit player to co-star, and it won’t be giving up that role anytime soon. As the COVID-19 pandemic swept across the United States last year, healthcare organizations that had been slow to embrace a virtual health model suddenly began implementing virtual care solutions at a breakneck pace. And […]

A Family Affair — Estela Lugo

March 1, 2021

I wish I could say there was a time in my life when I felt “normal,” but there really isn’t. Some of my first memories include sitting on the number rug in kindergarten and showing off my new plastic leg braces to friends. It was 1984 when doctors at Nassau County Medical Center in New […]

Decentralized Clinical Trials: The Way Forward

March 1, 2021

COVID-19 prompted the need for the industry to address patient needs in the clinical trial space, and companies along the drug development paradigm pivoted successfully to the benefit of patients. Necessity is the mother of invention, and over the past 12 to 18 months because of the limitations necessitated by COVID-19, clinical trials have undergone […]

Becoming a Patient Partner — Claire Snyman

March 1, 2021

May 14, 2010. I woke up to the room spinning. That day is forever etched in my mind. Firstly, because of the unfamiliar, sickening vertigo that rippled through my body, rendering me helpless. Secondly, because this symptom led to a cascade of events that four days later landed me in the ER diagnosed with a […]

Patient Heroes

March 1, 2021

Patient heroes have the power to positively change the status quo because of their influence, knowledge, passion, and commitment to improving the patient journey. The global patient engagement solutions market size is expected to reach $70.5 billion by 2028, according to a new report by Grand View Research. The market is expected to expand at […]

Advocate For Changes That Protect Patients — Molly Stallings

March 1, 2021

My mission is to create the best patient experience possible — from product development through program execution, each department plays a unique role in contributing to a patient’s overall experience. The consumerization of healthcare combined with the disruptive power of mobile technology presents new opportunities for pharmaceutical manufacturers to deliver services and support more effectively […]

Mission: Disrupt Health Disparities — Dr. Altovise Ewing

March 1, 2021

I envision a future of healthcare where genetics is used to advance health equity. I deem this a critical and possible mission, and believe our work at Genentech is a step in the right direction to getting us there. Dr. Altovise Ewing’s passion for health equity is personal. As a Black woman raised in the […]

SHOWCASE: Real-World Evidence: Realizing the Benefits of RWE

March 1, 2021

The real-world evidence (RWE) market has grown significantly in recent years, supported by a favorable regulatory environment. Increasingly, companies recognize that real-world evidence (RWE) presents an opportunity to improve efficiency and innovation. One of the biggest challenges for pharma companies is the time it takes to bring products to market. To shorten these timelines, companies […]

Four Key Considerations When Using Real-World Data in Drug Development and Regulatory Submissions

March 1, 2021

Interest in using real-world data (RWD) in drug development and regulatory submissions has grown substantially over the past several years. This development can largely be attributed to passage of the 21st Century Cures Act, which mandated that FDA establish a program to evaluate the use of real-world evidence (RWE) to support approval of new indications […]

Leveraging RWE to Enhance Experiences Across the Patient Journey

March 1, 2021

In a tech-driven healthcare ecosystem in which patients are engaged consumers, product value is contingent on treatment outcomes and patient success. With digital tools and resources at their fingertips, today’s patient is empowered to make informed treatment decisions; and physicians need enhanced support to ensure they’re meeting patient needs. Providing physicians with the tools to […]

Modernizing Oncology Approvals

March 1, 2021

Using real world evidence to bolster oncology accelerated approvals and label extensions Regulators are increasingly leveraging real world evidence (RWE) to inform their understanding of the benefits and risks of using targeted therapies in patients who are treated as part of routine clinical care, including patients who are very ill, who suffer from co-morbidities, or […]

Shot in the Arm: COVID-19 Boost to RWD

March 1, 2021

Times Have Changed It’s early 2021 in the Northeast and a major snowstorm has just been announced. Schools will be closed for the next two days. Kids will be home and likely, quite happy to be off from school. Under normal circumstances, parents would be home too, trying to work and probably attempting to create […]

The RWE Evolution

March 1, 2021

With so much attention being focused on real-world evidence (RWE) and real-world data (RWD), it would be easy to assume that this critical area of drug development is revolutionary. But, in fact, RWE has been around for decades and what the industry is currently experiencing is an evolution of processes founded in solid science and […]

Best Practices in Long-Term Safety Follow-Up Studies in Oncology

March 1, 2021

As the quest to develop more effective treatments for cancer continues, a growing number of therapies are receiving accelerated approval from the U.S. Food and Drug Administration (FDA).1 The percentage of new oncology drugs that have gone through the Accelerated Approval Program increased approximately 30% between 2012 and 2020.2 Accelerated approval often comes with a […]

20 Years in the Making: Special Section

March 1, 2021

From day one our goal has been to convene a community of experts who would be committed to our mission of: read, think, and participate. And you have. PharmaVOICE is proud to celebrate the contributions of thousands of thought leaders and subject matter experts who have lent their insights on a wide range of topics […]

Commanders & Chiefs: Chief Patient Officers

March 1, 2021

More and more companies are elevating patient-facing roles to the C-Suite, as a result, these key roles continue to expand and evolve to address the goals of patient-centricity and patient engagement. Dr. Julie Gerberding Merck Respecting Voices Across the Spectrum of Advocacy The concept of patient-centricity became visible in the 1980s and early 1990s, driven […]

Executive Perspective: A Learning Model: A Deployment Strategy for the Future

March 1, 2021

Throughout her 20-year-plus career, Jaime Thompson has become an expert in driving client launches and brand success through commercial and medical channels. Her deep analytical expertise provides customers with innovative ways to execute on their brand strategies — from the first launch of an oral oncolytic, to the design and build out of outcomes-based patient […]

Speak Out: Making Your Trial Break Through: How Imaging Can Make — or Break — Your Accelerated Trial

March 1, 2021

Breakthrough Therapy studies evaluate the effects of therapies on the most severe diseases, where patients have irreversible morbidity or mortality [IMM] or symptoms that represent serious outcomes of their sickness. The pressure to deliver quality data is immense because the cost of not delivering can result in patient deaths that may have been prevented. The […]

FEEDBACK